DNA Labs UAE is at the forefront of providing advanced diagnostic solutions for various genetic conditions and diseases, including multiple myeloma. Multiple myeloma is a type of blood cancer that affects the plasma cells in the bone marrow. These cancerous cells can lead to a myriad of health issues, including bone damage, anemia, and immune system deficiencies. One of the cutting-edge tests offered by DNA Labs UAE to diagnose and assess the progression of multiple myeloma is the FISH (Fluorescence In Situ Hybridization) test with Positive Selection of CD138 Cells. This specialized test, priced at 3040 AED, plays a crucial role in the personalized treatment and management of multiple myeloma.
Understanding the Symptoms of Multiple Myeloma
Multiple myeloma can manifest through a variety of symptoms, which may vary from person to person. Some individuals might experience mild symptoms or none at all in the early stages. However, as the disease progresses, the symptoms become more pronounced and can include:
- Bone pain, especially in the spine or chest
- Nausea
- Constipation
- Loss of appetite
- Weight loss
- Frequent infections
- Weakness or fatigue
- Excessive thirst
- Problems with kidney function
The Role of FISH Test with Positive Selection of CD138 Cells in Multiple Myeloma
The FISH test with Positive Selection of CD138 Cells is a sophisticated diagnostic tool used in the detection and management of multiple myeloma. This test focuses on isolating and examining plasma cells, specifically targeting the CD138+ cells, which are a hallmark of multiple myeloma. By employing fluorescence in situ hybridization, this test can identify genetic abnormalities that are often associated with multiple myeloma. These abnormalities can provide crucial information regarding the prognosis and guide the treatment plan for patients.
Benefits of the FISH Test with Positive Selection of CD138 Cells
This test offers several benefits for patients suspected of having multiple myeloma or those who are already diagnosed with the disease:
- Highly Specific: By targeting CD138+ cells, the test ensures high specificity in detecting the genetic abnormalities associated with multiple myeloma.
- Guides Treatment: The results can help in tailoring personalized treatment plans based on the genetic profile of the myeloma cells.
- Monitors Disease Progression: It can be used to monitor the disease’s progression or response to treatment over time.
- Predicts Prognosis: Certain genetic markers identified through this test can predict the disease’s aggressiveness and overall prognosis.
Test Cost and Procedure
The FISH test with Positive Selection of CD138 Cells is available at DNA Labs UAE for 3040 AED. The test is conducted in a state-of-the-art laboratory setting by experienced professionals. A sample of the patient’s blood or bone marrow is collected and then processed to isolate the CD138+ plasma cells. These cells are then analyzed using fluorescence in situ hybridization to detect any genetic abnormalities. The entire process is designed to be as seamless and comfortable for the patient as possible, ensuring accurate and reliable results.
Conclusion
The FISH test with Positive Selection of CD138 Cells is a powerful diagnostic tool for patients with multiple myeloma, offering insights that are critical for the personalized treatment and management of the disease. DNA Labs UAE is committed to providing this advanced testing service, aiding in the early detection, treatment planning, and monitoring of multiple myeloma. For more information about this test and to schedule an appointment, please visit DNA Labs UAE.
